Heidi Crane

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation
    Heidi M Crane
    Department of Medicine, Center for AIDS and STD, Seattle, WA, USA
    Int J STD AIDS 16:80-3. 2005
  2. ncbi Lipoatrophy and lipohypertrophy are independently associated with hypertension
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    HIV Med 10:496-503. 2009
  3. ncbi Optimal timing of routine vaccination in HIV-infected persons
    Heidi M Crane
    Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 6:93-9. 2009
  4. ncbi Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy
    H M Crane
    Center for AIDS and STD Research, Harborview Medical Center, University of Washington, Seattle, WA 98104, USA
    HIV Med 9:780-6. 2008
  5. ncbi Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care
    Heidi M Crane
    University of Washington, Seattle, Washington, USA
    AIDS 25:185-95. 2011
  6. ncbi Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, Washington, USA
    AIDS Patient Care STDS 21:920-9. 2007
  7. ncbi Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy
    Heidi M Crane
    Department of Medicine, Center for AIDS and STD Research, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104, USA
    AIDS 20:1019-26. 2006
  8. ncbi Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS 21:1431-9. 2007
  9. ncbi Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients
    Heidi M Crane
    The Department of Medicine, University of Washington, Seattle, Washington, USA
    Curr HIV Res 5:109-18. 2007
  10. ncbi Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patients
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, USA
    Curr HIV Res 4:97-106. 2006

Research Grants

  1. Lipodystrophy among HIV-infected patients
    Heidi Crane; Fiscal Year: 2007
  2. Optimal assessment of HAART adherence in routine clinical care
    Heidi M Crane; Fiscal Year: 2010

Detail Information

Publications16

  1. ncbi Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation
    Heidi M Crane
    Department of Medicine, Center for AIDS and STD, Seattle, WA, USA
    Int J STD AIDS 16:80-3. 2005
    ..This case also illustrates the possibility of cryptic visceral KS with minimal cutaneous disease, as well as the potential for differential responses of cutaneous and visceral KS to treatment...
  2. ncbi Lipoatrophy and lipohypertrophy are independently associated with hypertension
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    HIV Med 10:496-503. 2009
    ..Lipoatrophy and lipohypertrophy are associated with metabolic abnormalities, but little is known about their impact on hypertension. We conducted this study to determine the associations of lipoatrophy and lipohypertrophy with hypertension...
  3. ncbi Optimal timing of routine vaccination in HIV-infected persons
    Heidi M Crane
    Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA
    Curr HIV/AIDS Rep 6:93-9. 2009
    ..However, risks of delaying vaccination include that the patient may be exposed to the pathogen or lost to follow-up before vaccination. We review recent studies on the timing of routine vaccination of HIV-infected individuals...
  4. ncbi Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy
    H M Crane
    Center for AIDS and STD Research, Harborview Medical Center, University of Washington, Seattle, WA 98104, USA
    HIV Med 9:780-6. 2008
    ..We sought to determine the association between body morphology abnormalities and depression, examining lipoatrophy and lipohypertrophy separately...
  5. ncbi Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care
    Heidi M Crane
    University of Washington, Seattle, Washington, USA
    AIDS 25:185-95. 2011
    ..to assess the associations between nucleoside reverse transcriptase inhibitors (NRTIs) and change in lipid levels among a large cohort of HIV-infected patients in routine clinical care initiating their first potent antiretroviral regimen...
  6. ncbi Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, Washington, USA
    AIDS Patient Care STDS 21:920-9. 2007
    ....
  7. ncbi Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy
    Heidi M Crane
    Department of Medicine, Center for AIDS and STD Research, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104, USA
    AIDS 20:1019-26. 2006
    ..To examine the effect of antiretroviral agents and clinical factors on the development of elevated blood pressure (BP)...
  8. ncbi Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS 21:1431-9. 2007
    ..To examine the effect of antiretroviral agents and clinical factors on the development of tenofovir-associated kidney dysfunction...
  9. ncbi Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients
    Heidi M Crane
    The Department of Medicine, University of Washington, Seattle, Washington, USA
    Curr HIV Res 5:109-18. 2007
    ..We examined the feasibility of using a web-based application on tablet PCs with touch screens to collect PROs in a busy, multi-provider, outpatient HIV clinical care setting...
  10. ncbi Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patients
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, USA
    Curr HIV Res 4:97-106. 2006
    ..Accurately identifying HIV-infected patients with a diagnosis of diabetes in electronic medical record systems will facilitate the study of patients with this disease...
  11. ncbi A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care
    Heidi M Crane
    Department of Medicine, University of Washington, Seattle, Washington 98104, USA
    AIDS Patient Care STDS 20:161-74. 2006
    ..EVGGFP can be used to assess health status among HIV-infected patients in routine clinical care and may be useful in settings in which comprehensive HRQL assessment is not practical...
  12. ncbi The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals
    Mary K Tegger
    Department of Medicine, University of Washington, Seattle, Washington, USA
    AIDS Patient Care STDS 22:233-43. 2008
    ..Screening for these disorders in primary care settings and access to appropriate treatment are increasingly important components of providing care to HIV-infected patients...
  13. ncbi Effect of early versus deferred antiretroviral therapy for HIV on survival
    Mari M Kitahata
    University of Washington, Harborview Medical Center, 325 Ninth Ave, Box 359931, Seattle, WA 98104, USA
    N Engl J Med 360:1815-26. 2009
    ..The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain...
  14. ncbi Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
    Mari M Kitahata
    Department of Medicine, University of Washington, Seattle, 98195, USA
    Int J Epidemiol 37:948-55. 2008
  15. ncbi Tenofovir-associated decline in renal function
    Heidi M Crane
    J Infect Dis 198:937; author reply 937-8. 2008
  16. ncbi Blood pressure and antiretroviral therapy
    Heidi M Crane
    AIDS 21:1992-3. 2007

Research Grants5

  1. Lipodystrophy among HIV-infected patients
    Heidi Crane; Fiscal Year: 2007
    ..abstract_text> ..
  2. Optimal assessment of HAART adherence in routine clinical care
    Heidi M Crane; Fiscal Year: 2010
    ..Optimally and routinely assessing adherence in clinical settings is an important step toward maximizing the potential benefit of antiretroviral therapy for all patients. ..